GENFF (Genflow Biosciences) Total Equity: $-0.74 Mil (As of Dec. 2025)


What is Genflow Biosciences Total Equity?

Genflow Biosciences GENFF Total Equity is $-0.74 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Genflow Biosciences's total equity for the quarter that ended in Dec. 2025 was $-0.74 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Genflow Biosciences Total Equity Historical Data

* Premium members only.

The historical data trend for Genflow Biosciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genflow Biosciences Total Equity Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
0.07 2.88 0.63 -0.51 -0.74

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 1.09 -0.51 -0.41 -0.74

Genflow Biosciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Genflow Biosciences's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=0.605-1.343
=-0.74

Genflow Biosciences's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=0.605-1.343
=-0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-0.74 Mil mean?
Genflow Biosciences (GENFF) has a Total Equity of $-0.74 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Genflow Biosciences and its competitors.
Is Genflow Biosciences' Total Equity too high?
Genflow Biosciences' current Total Equity is $-0.74 Mil.
How does Genflow Biosciences' Total Equity compare to VRTX and REGN?
Genflow Biosciences' Total Equity of $-0.74 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Genflow Biosciences and its competitors. Genflow Biosciences's current Total Equity is $-0.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genflow Biosciences stock overvalued right now?
Genflow Biosciences (GENFF) has a current Total Equity of $-0.74 Mil. The current Total Equity is $-0.74 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Genflow Biosciences (GENFF), the current Total Equity is $-0.74 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genflow Biosciences Business Description

Other Exchanges GENF:UKWQ5:Germany
Address 6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on the development of biological interventions (namely gene therapies) which are aimed at tackling the effects of aging, potentially slowing or halting the aging process and so reducing the incidence of age-related diseases and thereby increasing health span. Its flagship compound, GF-1002, is based on the delivery of a variant of the SIRT6 gene and is currently in preclinical development.